ALISO VIEJO, CALIFORNIA, October 16, 2013 – Versant Ventures and U.S. Venture Partners back medical device start-up.

Inceptus Medical, LLC, a medical device company incubator, announced today that it has completed a $4.7M Series A financing for its first new company, Inari Medical Inc. The financing will provide the resources to develop and commercialize innovative devices for the interventional treatment of cardiovascular disease.

Versant Ventures and U.S. Venture Partners (USVP) led the funding round. “My colleagues at Versant and I are excited to be working with Inceptus to develop new medical device companies,” said Kirk Nielsen, Managing Director at Versant Ventures. Kirk Nielsen and Don Milder at Versant Ventures and Jonathan Root, M.D. at USVP will serve as board members.

“We are pleased to continue to work with Versant Ventures and USVP who have supported us to build two previous successful companies, MicroVention (acquired by Terumo) and Sequent Medical Inc.” said Bob Rosenbluth, Inceptus President & CEO. Inari Medical management, Bob Rosenbluth, Brian Cox and Paul Lubock will lead the company’s initial development, clinical evaluation and product launch.

About Inceptus Medical
Inceptus was founded in 2011 as a medical device company incubator with a mission to create and foster innovative concepts into companies by providing a combination of experienced engineering, clinical research expertise, seasoned leadership and strong financial resources. The Inceptus team includes talented medical device engineers, serial entrepreneurs, executive managers and investors with a successful track record in the formation of medical device companies. Inceptus works closely with outside clinicians and inventors with promising ideas.

For more information, visit the company’s website at